Analyst Models NeurAxis 12-Month Share Price Target At $14,

Having just 1.21 million outstanding shares typically presents exceptionally well to a growth stock investor. But while it can fuel appreciable gains quickly, it can also cause downward pressure....

Related Keywords

Boston , Massachusetts , United States , Brian Carrico , Jack Enterprises , Neuraxis Inc , Boston Scientific Corp , Goldman Small Cap Research , Goldman Smallcap Research , Hawk Point Media Group Llc , Irritable Bowel Syndrome , Functional Abdominal Pain , Percutaneous Electrical Nerve Field Stimulation , Price To Reach , Smallcap Research , Big Pharma , Earning Considerable , Chief Executive Officer , Immediate Post Concussion Assessment , Post Concussion Symptom Scale , Balance Error Scoring Symptom , Small Cap Research , Point Media Group , Eyed Jack Enterprises , Private Securities Litigation Reform Act , Hawk Point , Markets ,